These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34531934)

  • 1. The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients.
    Habib G; Khazin F; Artul S
    Pain Res Manag; 2021; 2021():1756588. PubMed ID: 34531934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CHARACTERISTICS OF MEDICAL CANNABIS USAGE AMONG PATIENTS WITH FIBROMYALGIA].
    Habib G; Levinger U
    Harefuah; 2020 May; 159(5):343-348. PubMed ID: 32431124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of medical cannabis treatment.
    Habib G; Aamar S
    J Investig Med; 2022 Feb; 70(2):446-448. PubMed ID: 35022250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study.
    Sznitman SR; Vulfsons S; Meiri D; Weinstein G
    BMJ Support Palliat Care; 2020 Dec; 10(4):415-420. PubMed ID: 31959585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
    Morean ME; Lederman IR
    Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical cannabis treatment for chronic pain: Outcomes and prediction of response.
    Aviram J; Pud D; Gershoni T; Schiff-Keren B; Ogintz M; Vulfsons S; Yashar T; Adahan HM; Brill S; Amital H; Goor-Aryeh I; Robinson D; Green L; Segal R; Fogelman Y; Tsvieli O; Yellin B; Vysotski Y; Morag O; Tashlykov V; Sheinfeld R; Goor R; Meiri D; Eisenberg E
    Eur J Pain; 2021 Feb; 25(2):359-374. PubMed ID: 33065768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms.
    Gruber SA; Smith RT; Dahlgren MK; Lambros AM; Sagar KA
    Exp Clin Psychopharmacol; 2021 Apr; 29(2):147-156. PubMed ID: 33764103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain.
    Cranford JA; Arnedt JT; Conroy DA; Bohnert KM; Bourque C; Blow FC; Ilgen M
    Drug Alcohol Depend; 2017 Nov; 180():227-233. PubMed ID: 28926791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical cannabis and cognitive performance in middle to old adults treated for chronic pain.
    Sznitman SR; Vulfsons S; Meiri D; Weinstein G
    Drug Alcohol Rev; 2021 Feb; 40(2):272-280. PubMed ID: 32964502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Consumption of Cannabis by Fibromyalgia Patients in Israel.
    Habib G; Avisar I
    Pain Res Treat; 2018; 2018():7829427. PubMed ID: 30140459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.
    Aviram J; Lewitus GM; Pud D; Procaccia S; Berman P; Yellin B; Vysotski Y; Hazan O; Eisenberg E; Meiri D
    Pharmacol Res; 2021 Jul; 169():105651. PubMed ID: 34000362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls.
    Hjorthøj C; La Cour P; Nordentoft M; Posselt CM
    Eur J Pain; 2022 Feb; 26(2):480-491. PubMed ID: 34624164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Cannabis for the Treatment of Fibromyalgia.
    Habib G; Artul S
    J Clin Rheumatol; 2018 Aug; 24(5):255-258. PubMed ID: 29461346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
    Eisenberg E; Ogintz M; Almog S
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study.
    Fitzcharles MA; Rampakakis E; Sampalis JS; Shir Y; Cohen M; Starr M; Häuser W
    Clin Exp Rheumatol; 2021; 39 Suppl 130(3):115-119. PubMed ID: 33938797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain.
    Feingold D; Goor-Aryeh I; Bril S; Delayahu Y; Lev-Ran S
    Pain Med; 2017 Feb; 18(2):294-306. PubMed ID: 28204792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Cannabis for Neuropathic Pain.
    Lee G; Grovey B; Furnish T; Wallace M
    Curr Pain Headache Rep; 2018 Feb; 22(1):8. PubMed ID: 29388063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes.
    Shah A; Craner J; Cunningham JL
    J Subst Abuse Treat; 2017 Jun; 77():95-100. PubMed ID: 28476279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain.
    Perron BE; Holt KR; Yeagley E; Ilgen M
    Drug Alcohol Depend; 2019 Jan; 194():401-409. PubMed ID: 30500688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.